striatin
Recombinant proteinexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
2
Phase 4
0
Earliest trial started Aug 31, 2024 (NCT06558071)
Timeline
2020s
- Jan 1, 2024
Earliest Phase 3 Sponsor(trial)
Indications
Mechanism of action
- StriatinSupplementation
STRN supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07089329 | Phase 3 | May 20, 2025 | Dexa Medica Group, Universitas Sriwijaya |
| NCT06933862 | N/A | May 15, 2025 | Dexa Medica Group, University of Indonesia |
| NCT06558071 | Phase 3 | Aug 31, 2024 | Dexa Medica Group |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Dexa Medica Group | For profit | 3 | 1 | 2 | 2024 |
| Universitas Sriwijaya | Academic/Hospital | 1 | 1 | 1 | 2025 |
| University of Indonesia | Academic/Hospital | 1 | 1 | 1 | 2025 |
3 organizations
Page 1 / 1